UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000037848
Receipt number R000043151
Scientific Title A Study on the effect of eicosapentaenoic acid ・docosahexaenoic acid on mental fatigue
Date of disclosure of the study information 2019/08/31
Last modified on 2020/02/03 16:54:02

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A Study on the effect of eicosapentaenoic acid ・docosahexaenoic acid on mental fatigue

Acronym

Effect of eicosapentaenoic acid ・docosahexaenoic acid on mental fatigue

Scientific Title

A Study on the effect of eicosapentaenoic acid ・docosahexaenoic acid on mental fatigue

Scientific Title:Acronym

Effect of eicosapentaenoic acid ・docosahexaenoic acid on mental fatigue

Region

Japan


Condition

Condition

Healthy adults

Classification by specialty

Not applicable Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the effect of eicosapentaenoic acid・docosahexaenoic acid on mental fatigue

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

・Subjective symptom questionnaire on fatigue (VAS) before and after mental workload
・Subjective symptom questionnaire on fatigue (VAS) for awakening

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Prevention

Type of intervention

Food

Interventions/Control_1

Test food: intake of fish oil containing eicosapentaenoic acid ・docosahexaenoic acid
6 capsules/day, 12 weeks

Interventions/Control_2

Placebo food: intake of corn oil not containing eicosapentaenoic acid ・docosahexaenoic acid
6 capsules/day, 12 weeks

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

35 years-old <=

Age-upper limit

60 years-old >

Gender

Male and Female

Key inclusion criteria

1) Subjects who tend to get tired easily by usual desk works
2) Healthy males and females aged 35 to 60 years old at the time of acquiring informed consent
3) Subjects who can make self-judgement and are voluntarily giving written informed consent

Key exclusion criteria

1) Subjects who have a history of serious liver disorder, kidney disorder, heart disease
2) Subjects who are suffering from diseases and who are visiting hospital, medication or treatment
3) Subjects who are suspected to be depression or menopausal disorder
4) Subjects who have ever been diagnosed with chronic fatigue syndrome
5) Subjects who are likely to have allergic symptoms due to the tested component
6)Subjects who eat blue fish (maize, mackerel, sardine, saury, etc) for more than 4 days a week
7) Subjects who are taking medicines (such as pharmaceuticals based on ethyl icosapentate) or supplements (EPA, DHA, GABA, citric acid, imidazole dipeptide, astaxanthin, Coenzyme Q10 etc.) that have an influence on the test results
8)Subjects who is pregnant or willing to be pregnant or breast-feeding during this study
9) Subjects with irregular shift work and late night work
10) Subjects who exercise for over an hour every day
11)Alcoholic drinkers (more than 60 grams of pure alcohol per day for more than 5 days a week)
12) Subjects participating in other clinical trials or willing to participate in other clinical trials
13) Subjects who are judged as unsuitable for the study by the investigator for other reasons

Target sample size

60


Research contact person

Name of lead principal investigator

1st name Satoru
Middle name
Last name Suzuki

Organization

Shinagawa Season terrace Health Care clinic

Division name

General Manager of Medical Examination Department/ Doctor

Zip code

108-0075

Address

5F Shinagawa Season Terrace Bld., 1-2-70 Kounan, Minato-ku, Tokyo, Japan

TEL

03-3452-3382

Email

satoru_suzuki@sempos.or.jp


Public contact

Name of contact person

1st name Yoshika
Middle name
Last name Komori

Organization

KSO Co., Ltd

Division name

Sales department

Zip code

105-0023

Address

7F Shibaura Omodaka Bld., 1-9-7 Shibaura, Minato-ku, Tokyo, Japan

TEL

03-3452-7733

Homepage URL


Email

yoshi@kso.co.jp


Sponsor or person

Institute

KSO Co., Ltd

Institute

Department

Personal name



Funding Source

Organization

Nippon Suisan Kaisha, Ltd.,

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Ethical Committee of Shinagawa Season Terrace Health Care Clinic

Address

5F Shinagawa Season Terrace Bld., 1-2-70 Kounan, Minato-ku, Tokyo, Japan

Tel

03-3452-3382

Email

tomohiro_kogo@sempos.or.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

一般財団法人船員保険会 品川シーズンテラス健診クリニック


Other administrative information

Date of disclosure of the study information

2019 Year 08 Month 31 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

60

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2019 Year 08 Month 05 Day

Date of IRB

2019 Year 08 Month 15 Day

Anticipated trial start date

2019 Year 08 Month 31 Day

Last follow-up date

2019 Year 12 Month 15 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2019 Year 08 Month 29 Day

Last modified on

2020 Year 02 Month 03 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000043151


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name